Protillion Biosciences Funding & Investors
Burlingame, CA
Protillion Biosciences is a Stanford University spinout commercializing disruptive technology for therapeutic antibody and binder discovery. We have developed an entirely novel, powerful and high-throughput protein display platform designed to revolutionize traditional approaches to the design and development of protein-based drugs.
protillion.comTotal Amount Raised: $18,000,000
Protillion Biosciences Funding Rounds
Series A
$18,000,000
Series A Investors
Arch Venture PartnersIllumina Ventures
Funding info provided by Diffbot.